KHK, PNPLA3 and PPAR as Novel Targets for the Anti-Steatotic Action of Bempedoic Acid
Bempedoic acid (BemA) is an ATP-citrate lyase (ACLY) inhibitor used to treat hypercholesterolemia. We studied the anti-steatotic effect of BemA, and the mechanisms involved, in a model of fatty liver in female rats obtained through the administration of a high-fat diet supplemented with liquid fruct...
Main Authors: | Alegret, M. (Author), Bentanachs, R. (Author), Laguna, J.C (Author), Lázaro, I. (Author), Rodríguez-Morató, J. (Author), Roglans, N. (Author), Sala-Vila, A. (Author), Sánchez, R.M (Author), Velázquez, A.M (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI
2022
|
Subjects: | |
Online Access: | View Fulltext in Publisher |
Similar Items
-
Bempedoic acid for the treatment of dyslipidemia
by: Joel C Marrs, et al.
Published: (2020-08-01) -
Efficacy and safety of bempedoic acid for prevention of cardiovascular events and diabetes: a systematic review and meta-analysis
by: Xing Wang, et al.
Published: (2020-08-01) -
Bempedoic Acid for Heterozygous Familial Hypercholesterolemia: From Bench to Bedside
by: Agarwala A, et al.
Published: (2021-05-01) -
MdFRK2-mediated sugar metabolism accelerates cellulose accumulation in apple and poplar
by: Jing Su, et al.
Published: (2021-06-01) -
Identification and biochemical characterization of the fructokinase gene family in Arabidopsis thaliana
by: John W. Riggs, et al.
Published: (2017-04-01)